Princeton, NJ, United States of America

Shih-jung Lan

This inventor holds 4 USPTO granted patents. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1981-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shih-jung Lan. Retrieved from https://idiyas.com/inventor/shih-jung-lan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1981-1982

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Shih-jung Lan

Introduction

Shih-jung Lan is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of pharmaceuticals. He holds a total of four patents, showcasing his innovative approach to developing new compounds.

Latest Patents

Among his latest inventions are mixed disulfides, which are directed to compounds of a specific formula. These compounds, wherein A and A.sub.1 are amino acid residues, X is an .alpha.-imino acid residue, and R.sub.1 is hydrogen, lower alkyl, or halo substituted lower alkyl, are recognized for their utility as hypotensive agents. This invention highlights his commitment to advancing medical science and improving health outcomes.

Career Highlights

Shih-jung Lan is associated with E.R. Squibb & Sons, Inc., a company known for its dedication to pharmaceutical innovation. His work there has allowed him to focus on developing compounds that can have a significant impact on patient care.

Collaborations

He has collaborated with esteemed colleagues such as Sesha I Natarajan and Miguel A Ondetti, further enhancing the quality and scope of his research.

Conclusion

Shih-jung Lan's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his innovative spirit and dedication to improving health solutions. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…